Brainstorm Cell Therapeutics - 53 Year Dividend History | BCLI
Historical dividend payout and yield for Brainstorm Cell Therapeutics (BCLI) since 1971. The current TTM dividend payout for Brainstorm Cell Therapeutics (BCLI) as of November 21, 2024 is $0.00. The current dividend yield for Brainstorm Cell Therapeutics as of November 21, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.007B |
$0.000B |
|
BrainStorm Cell Therapeutics Inc. is a biotechnology company. It develops autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Multiple Sclerosis and Parkinson's disease. Brainstorm Cell Therapeutics is based in New York.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
